tyrosyl-alanyl-glycine has been researched along with cephalothin in 1 studies
| Studies (tyrosyl-alanyl-glycine) | Trials (tyrosyl-alanyl-glycine) | Recent Studies (post-2010) (tyrosyl-alanyl-glycine) | Studies (cephalothin) | Trials (cephalothin) | Recent Studies (post-2010) (cephalothin) |
|---|---|---|---|---|---|
| 21 | 1 | 7 | 2,621 | 196 | 94 |
| Protein | Taxonomy | tyrosyl-alanyl-glycine (IC50) | cephalothin (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 isoform b | Homo sapiens (human) | 7.28 | |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 2.786 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
1 other study(ies) available for tyrosyl-alanyl-glycine and cephalothin
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |